Te Ahumairangi Investment Management Ltd Has $1.93 Million Stake in Sabra Health Care REIT, Inc. (NASDAQ:SBRA)

Te Ahumairangi Investment Management Ltd lessened its stake in shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRA) by 16.1% during the fourth quarter, Holdings Channel reports. The fund owned 111,306 shares of the real estate investment trust’s stock after selling 21,314 shares during the quarter. Te Ahumairangi Investment Management Ltd’s holdings in Sabra Health Care REIT were worth $1,928,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also bought and sold shares of the stock. Geode Capital Management LLC raised its holdings in shares of Sabra Health Care REIT by 1.7% during the third quarter. Geode Capital Management LLC now owns 6,294,798 shares of the real estate investment trust’s stock valued at $117,165,000 after purchasing an additional 104,533 shares during the period. JPMorgan Chase & Co. increased its position in Sabra Health Care REIT by 222.4% in the 3rd quarter. JPMorgan Chase & Co. now owns 9,886,917 shares of the real estate investment trust’s stock valued at $183,996,000 after buying an additional 6,819,919 shares in the last quarter. Vestcor Inc raised its stake in Sabra Health Care REIT by 62.5% during the 3rd quarter. Vestcor Inc now owns 207,918 shares of the real estate investment trust’s stock worth $3,869,000 after buying an additional 79,956 shares during the period. Barclays PLC boosted its holdings in Sabra Health Care REIT by 56.1% in the third quarter. Barclays PLC now owns 678,397 shares of the real estate investment trust’s stock worth $12,624,000 after acquiring an additional 243,895 shares in the last quarter. Finally, Franklin Resources Inc. grew its stake in Sabra Health Care REIT by 12.3% in the third quarter. Franklin Resources Inc. now owns 524,917 shares of the real estate investment trust’s stock valued at $9,543,000 after acquiring an additional 57,551 shares during the period. 99.40% of the stock is owned by institutional investors.

Sabra Health Care REIT Stock Performance

NASDAQ SBRA opened at $17.50 on Wednesday. The company has a fifty day moving average price of $16.85 and a 200-day moving average price of $17.66. The firm has a market cap of $4.16 billion, a price-to-earnings ratio of 33.02, a PEG ratio of 1.97 and a beta of 1.27. The company has a debt-to-equity ratio of 0.88, a current ratio of 4.32 and a quick ratio of 4.16. Sabra Health Care REIT, Inc. has a 1 year low of $13.31 and a 1 year high of $20.03.

Sabra Health Care REIT (NASDAQ:SBRA) last issued its quarterly earnings data on Wednesday, February 19th. The real estate investment trust reported $0.36 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.36. The business had revenue of $182.35 million during the quarter, compared to the consensus estimate of $178.01 million. Sabra Health Care REIT had a net margin of 18.02% and a return on equity of 4.60%. As a group, equities research analysts predict that Sabra Health Care REIT, Inc. will post 1.45 EPS for the current fiscal year.

Sabra Health Care REIT Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, February 28th. Investors of record on Friday, February 14th were given a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a dividend yield of 6.86%. The ex-dividend date of this dividend was Friday, February 14th. Sabra Health Care REIT’s payout ratio is 226.42%.

Wall Street Analyst Weigh In

A number of brokerages have recently weighed in on SBRA. Truist Financial upped their target price on Sabra Health Care REIT from $17.00 to $18.00 and gave the stock a “hold” rating in a research report on Tuesday, March 18th. JMP Securities raised shares of Sabra Health Care REIT from a “market perform” rating to an “outperform” rating and set a $20.00 price objective on the stock in a research note on Tuesday, January 7th. Mizuho reiterated a “neutral” rating and set a $20.00 price objective on shares of Sabra Health Care REIT in a report on Thursday, December 5th. Finally, Citizens Jmp upgraded shares of Sabra Health Care REIT from a “hold” rating to a “strong-buy” rating in a report on Tuesday, January 7th. Three equities research analysts have rated the stock with a hold rating, three have issued a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $19.33.

About Sabra Health Care REIT

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.